Investigation of Demographic Differences for Non-Small Cell Lung Cancer Patients with and Without Type 2 Diabetes
The incidence of type 2 diabetes (T2D) in patients with non-small cell lung cancer (NSCLC) may be higher compared to the general population as there is a likely association with hyperinsulinemia, which is a result of insulin resistance characteristic of T2D. Insulin's role in cell proliferation through the action of insulin-like growth factor-1, as well as inhibition of apoptosis, could play a significant role in the development of cancerous tissues. Our objective was to characterize the demographic differences in incident NSCLC patients with and without T2D.
Source: Value in Health - Category: International Medicine & Public Health Authors: C Ruban, CM Blanchette, R Howden, M Kowalkowski, J Marino, W Saunders Source Type: research
More News: Cancer | Cancer & Oncology | Diabetes | Diabetes Type 2 | Endocrinology | Insulin | Lung Cancer | Non-Small Cell Lung Cancer